AVANOS MEDICAL, INC.
AVNSCIK 0001606498
Revenue (TTM)
$702.5M
+1.9% YoY
Q1 Apr 2026
Net Income (TTM)
−$66.5M
+81.4% YoY
Q1 Apr 2026
EPS Diluted (TTM)
−$1.44
+81.6% YoY
Q1 Apr 2026
Gross Margin
51.5%
Q1 Apr 2026
Operating Margin
-7.9%
Q1 Apr 2026
Net Margin
-9.5%
Q1 Apr 2026
Free Cash Flow (TTM)
−$20.5M
Q1 Apr 2026
Cash
$65.6M
Q1 Apr 2026
Total Debt
$226.3M
Q1 Apr 2026
Shares Outstanding
46.82M sh
Q1 Apr 2026